Lung Cancer
Conditions
Keywords
mediastinoscopy, pleural evaluation, pleural biopsy, pleurodesis
Brief summary
Although thoracic NOTES may not be ready for human trials, a new minimally invasive technique to access the pleural cavity and perform pleural, pulmonary and mediastinal procedures would be possible. Cervical Video Assisted Thoracoscopic Surgery (C-VATS) is a technique that borrows from traditional VATS procedures, from cervical mediastinoscopy, and from flexible endoscopy. All of these procedures are very familiar to the thoracic surgeon. The current feasibility and safety study examines C-VATS as a method of evaluating, biopsying and performing pleurodesis in patients with pleural disease and or effusion.
Detailed description
Hypothesis: C-VATS is a feasible and safe method of entering the pleural space in order to perform pleural evaluation, pleural biopsy and pleurodesis in patients with pleural disease and/or pleural effusions. Objectives: Evaluate the safety and feasibility of C-VATS in patients with pleural disease. Design: Prospective, cohort, feasibility and safety study. Methods: Patients referred to all thoracic surgeons in the Division of Thoracic Surgery at the CHUM Notre Dame campus for the diagnosis or treatment of pleural based diseases will be screened for enrolment. The investigators plan to recruit 10 patients in this initial study. Eligible patients will be consented by one of the thoracic surgeons at the CHUM. All procedures will be performing in the operating room at the CHUM Notre Dame Hospital. All patients will be admitted prior to their procedure and treated on the post-operative thoracic surgery ward using standard post-VATS procedural treatments. All cause, as well as procedure specific morbidity will be recorded by the study investigators on the day of the procedure, every day in hospital until discharge and at 1 week, 4 weeks and 12 weeks post procedure.
Interventions
PROCEDURECervical mediastinoscopy
minimally invasive technique to perform pleural evaluation, pleural biopsy and pleurodesis
Sponsors
Centre hospitalier de l'Université de Montréal (CHUM)
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Eligible patients will be those that would be candidates for the same pleural procedure (biopsy, drainage and pleurodesis) using a VATS technique
Exclusion criteria
* Anticoagulation including Warfarin, Heparin or Clopidogrel which cannot be stopped * Patients less than 18 years old * Pregnant patients * Patient unable to extend neck fully * Patients with cervical spine instability * Patients having had previous neck or mediastinal surgery which would preclude mediastinoscopy * Patients having previously undergone mediastinal irradiation * Patients having been previously diagnosed with mediastinitis * Active cervical cutaneous or deep cervical infections
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| procedure-related morbidity | 30 days | Intra-operative mortality In-hospital mortality 30-day mortality |
Secondary
| Measure | Time frame |
|---|---|
| pain related to technique | 3-6months |
| Procedural, hospitalization and overall cost | 3 months |
Countries
Canada
Outcome results
None listed